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Objective: To evaluate the predictive value of the Radius, Exophytic, Nearness, Ante-
rior, Location nephrometry scoring system and to investigate the inﬂuence of its
individual components on perioperative outcomes of minimally invasive partial
nephrectomy.
Methods: Consecutive laparoscopic partial nephrectomy (n = 189) and robotic partial
nephrectomy (n = 109) cases from 2007 through 2011 were retrospectively reviewed
from our prospectively maintained database. Urological surgeons assigned nephrom-
etry scores, excluding cases without images available for review. The association of
nephrometry score categories and individual components of the score to perioperative
outcomes were assessed.
Results: No differences were observed in preoperative characteristics of low
(n = 135), intermediate (n = 155) and high (n = 8) nephrometry groups. Higher nephrom-
etry score was associated with an increased length of stay, estimated blood loss and
warm ischemia time. Higher nephrometry scores were also associated with a greater
proportion of major complications (P < 0.001). Distance to the renal sinus had the great-
est impact on perioperative outcomes including operative and ischemic times, esti-
mated blood loss, complications and length of stay.
Conclusions: The Radius, Exophytic, Nearness, Anterior, Location nephrometry score
has value as a predictive tool for perioperative outcomes of minimally invasive partial
nephrectomy. Distance to the renal sinus seems to have the greatest association with
outcomes. Using these ﬁndings, clinicians will be better able to counsel patients regard-
ing anticipated perioperative outcomes of minimally invasive partial nephrectomy.
Key words: kidney neoplasms, laparoscopy, nephron-sparing surgery, renal cell car-
cinoma, robotics.
Introduction
Although recent trends have shown an increase in the use of minimally invasive and
nephron-sparing approaches to the management of small renal masses, these techniques can
be challenging and might pose a greater risk of perioperative morbidity to the patient.1
Existing data on the perioperative outcomes of minimally invasive nephron sparing surgery
(MI-NSS) is derived from single or multi-institutional case series. Only a handful of studies
have examined the impact of individual tumor and patient factors on outcomes of MI-NSS.2
Understanding the potential morbidity of a particular approach to the management of
a small renal mass based on individual patient factors could aid in making treatment
decisions.
Recently, several renal tumor scoring systems have been developed to provide a common
nomenclature to better describe renal masses and objectively predict the difficulty of
resection. The RENAL nephrometry score has the advantage of being adaptable and repro-
ducible, determined by five anatomical characteristics of the mass.3 Several series have
evaluated the impact of nephrometry on medical decision-making, perioperative outcomes
and short-termoncological outcomes;4–7 however, a recent series failed to showan association
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between nephrometry and perioperative outcomes.8 Mean-
while, no study has investigated the impact of the individual
components of the nephrometry score on outcomes.
We sought to externally validate the association of
RENAL nephrometry with perioperative outcomes using a
large single institution cohort of patients undergoing
MI-NSS. We also evaluated the significance of individual
components of the scoring system on perioperative out-
comes in order to offer insight into the value of these indi-
vidual components.
Methods
Patient selection
All patients undergoing either CLPN, HAPN or RAPN for
suspected malignancy from January 2007 to January 2011
were identified in our single-institution, prospectively main-
tained, Institutional review board-approved database and ret-
rospectively reviewed. Conversions to radical nephrectomy
were included (2 CLPN cases converted because of hemor-
rhage, and three RAPN cases converted for oncological
control).
RENAL nephrometry
RENAL nephrometry scores were assigned as described by
Kutuzov and Uzzo.3 The numerical total is a sum of indi-
vidual tumor characteristics, each assigned a point from
1–3, where a lower score indicates a less complex tumor.
Included in this sum are radius (4 cm, 4–7 cm, and
7 cm), endophytic nature of the tumor (50% exophytic,
<50% exophytic or endophytic), nearness to the renal sinus
(4 mm, 4–7 mm, or 7 mm) and polar location of the
tumor (50% crossing the interpolar lines, >50% crossing
the interpolar lines, 100% within the polar lines). The alpha-
betical indicators include A, P or x for anterior, posterior or
indeterminate tumors, respectively. Hilar tumors are defined
as tumors that abut the renal hilum.
Data acquisition
Chart and imaging reviews were retrospectively carried out
by four study investigators for procedures carried out before
May 2010, and were captured prospectively from that point
forward. Recent studies have suggested good interobserver
reliability of nephrometry scoring.9,10 If imaging was una-
vailable, the patient was excluded from analysis. Tumors
were stratified by RENAL score into low (4–6 points), inter-
mediate (7–9 points) or high (10–12 points) groups.3 Com-
plications were categorized using the Clavien Classification
system.11 Clavien scores less than or equal to 2 were con-
sidered “minor”, whereas those greater than 2 were consid-
ered “major” complications. Both early (within 30 days of
surgery) and late (after 30 days of surgery) complications
were included. Intraoperative complications were events
requiring altered intraoperative management (i.e. damage to
viscous or vascular structures requiring repair or hemor-
rhage requiring intraoperative blood transfusion). Addi-
tional demographic/patient characteristics (age at operation,
BMI, ASA score), perioperative information (WIT, LOS,
EBL and operative time) and pathological data were
abstracted from the database. EGFR was calculated using
the Modification of Diet in Renal Disease equation,12 utiliz-
ing the last creatinine on record during follow up, with a
mean follow up of 9 months.
Surgical technique
All procedures were carried out by one of eight attending
urological surgeons at a single academic institution. Robotic
procedures were carried out using the DaVinci surgical
system (Intuitive Surgical, Sunnyvale, CA, USA). Surgical
approach (CLPN, HAPN, RAPN) was determined at the
discretion of the attending surgeon. Our institutional algo-
rithm for management of renal masses at the time of mini-
mally invasive partial nephrectomy with regards to hilar
clamping, management of the tumor bed and transperitoneal
or retroperitoneal approach has been previously described.13
Standardized care pathways were used to manage patients
postoperatively.
Data analysis
Preoperative characteristics, perioperative outcomes and
complications were compared among “low” and “interme-
diate” complexity tumors. “High” complexity tumors were
excluded from categorical analysis of outcomes given low
numbers, but an additional analysis utilizing all strata of
nephrometry as a continuous variable in order to minimize
the limitations of a small number of “high” complexity
tumors was carried out, with results computed by linear
regression. A sub-analysis of groups separated by surgical
approach (RAPN, CLPN and HAPN) was also carried out.
Bivariate comparisons of preoperative and perioperative
characteristics and complications were carried out using
t-test, Kruskal–Wallis test or Mantel–Haenszel c2-test. Mul-
tivariable comparisons evaluating individual components of
the RENAL score were explored by including all individual
components in the starting model. Final models were then
constructed using a backwards selection method. All statis-
tical tests were two-tailed and carried out at the 5% signifi-
cance level. Analyses were carried out using the SAS V9.13
system (SAS Institute, Cary, NC, USA).
Results
A total of 298 out of 320 possible patients had all necessary
data for analysis, including 109 RAPN, 36 HAPN and 153
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CLPN. The average nephrometry score for the entire cohort
was 6.6. There were 135 “low”, 155 “intermediate” and
eight “high” nephrometry score tumors.A total of 28 tumors
qualified as hilar. Preoperative characteristics, including age
at operation, BMI, ASA score, preoperative eGFR and
number of patients with stage 3 or greater chronic kidney
disease (eGFR <60) were similar among groups, as seen in
Table 1. RAPN utilization increased with increasing neph-
rometry score, accounting for 30%, 41% and 63% of “low”,
“intermediate” and “high” tumors, respectively (P = 0.05).
Intraoperative and postoperative outcomes are detailed in
Table 2. EBL, WIT and operative time were significantly
greater in the “intermediate” group as compared with the
“low” group. Likewise, intraoperative complications were
significantly greater in the “intermediate” group (n = 17) as
compared with the “low” group (n = 2; P = 0.0038). Evalu-
ation of the RENAL score as a continuous variable con-
firmed no difference in preoperative parameters. Linear
regression of postoperative outcomes showed significant
differences in LOS (R = 0.1994; P = 0.0008), EBL
(R = 0.1486; P = 0.0108), operative time (R = 0.3618,
P < 0.0001) and WIT (R = 0.5065, P < 0.0001).
Postoperatively, LOS increased significantly as the neph-
rometry score increased (P = 0.003). There was no differ-
ence in the postoperative eGFR, number of patients with
eGFR less than 60 mg/mL/1.73 m2 or the number of patients
who developed eGFR less than 60 mg/mL/1.73 m2 postop-
eratively. The distance to the renal sinus was independently
associated with longer LOS (P < 0.0001).
Table 3 summarizes complications among the nephrom-
etry groups. Major complications comprised 25% of all
complications in the “intermediate” group and just 7% of all
complications in the “low” group, with the remainder in
each group being minor complications (P = 0.013). “Other”
complications accounted for a large proportion of all com-
plications, and included rhabdomyolysis, ureteral injury,
urinary retention, ileus, urinary tract infection, Clostridium
difficile infection, partial small bowel obstruction, unrecog-
Table 1 Preoperative characteristics by RENAL nephrometry score
Low (n = 135) Intermediate (n = 155) P
Age at operation (years) 56  13.9 58  12.6 0.18
BMI 29.7  7.54 30.2  6.02 0.59
ASA (median)
1–2 84 (62%) 94 (61%) 0.81
3–4 51 (38%) 61 (39%)
eGFR 84.2  23.5 83.4  21.9 0.71
eGFR <60 21 (15.5%) 20 (12.9%) 0.10
Values presented as mean  SD.
Table 2 Intraoperative and postoperative outcomes by RENAL nephrometry score
Intraoperative outcomes Low
(n = 135)
Intermediate
(n = 155)
P
Estimated Blood Loss (mL) (median and range) 150 (5–1700) 300 (10–9000) 0.0019
Warm Ischemia Time (min) 14.5  13.4 28.2  13.0 0.0001
Operative Time (min) 162  57.8 207  61.3 0.001
Transfusion requirement 5 (3.7%) 15 (9.7%) 0.0617
Positive margins 11 (12%) 6 (4%) 0.0356
RAPN 41 (30%) 63 (41%) 0.0856
CLPN + HAPN 94 (70%) 92 (59%)
Postoperative outcomes Low Intermediate P
Length of Stay (days) 2.2  1.63 3.1  2.5 0.0007
eGFR 84.7  23.8 80.0  25.3 0.1042
eGFR <60 17 (12.6%) 27 (17.4%) 0.325
New onset eGFR <60 4 (3.0%) 10 (6.5%) 0.1725
Values presented as mean  SD unless otherwise noted.
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nized bowel injury, common bile duct injury, anemia, renal
infarction, fever, diarrhea, emesis, hypertension, uncon-
trolled postoperative pain, acalculous cholecystitis, consti-
pation, altered mental status, epididymitis, gout flare,
hyperbilirubinemia, superior vena cava thrombus, and ure-
thral stricture. The proportions of hemorrhagic and pulmo-
nary complications were higher in the “intermediate” group
than in the “low” group, although this difference did not
reach statistical significance. The distribution of the remain-
der of complications including renal failure and urine leak
were similar between the “low” and “intermediate” groups.
Intraoperative complications included hemorrhage requir-
ing transfusion, damage to an accessory renal artery, and
injuries to the renal vein, vena cava and ureter (repaired
laparoscopically on separate occasions), as well as injury to
the common bile duct (repaired with an open operation).
A sub-analysis was carried out, including only those
patients with “minor” complications. In this subgroup of
patients, there was no difference between the median EBL
or transfusion rate, although there was still a significant
increase in WIT (P < 0.0001), LOS (0.03) and operative
times (P < 0.0001) with increasing nephrometry score.
Thus, the association of higher nephrometry scores and
longerWIT, LOS, and operative time cannot be solely attrib-
uted to a higher rate of major complications alone.
A sub-analysis evaluating individual surgical approaches
(RAPN, CLPN and HAPN) was also carried out. Preopera-
tive characteristics of BMI, preoperative eGFR and ASA
were similar among tumor complexities in all subgroups,
although patients in higher tumor complexity groups tended
to be older in the RAPN and HAPN cohorts (data not
shown). All groups showed significant increases in operative
and ischemic time with increasing RENAL scores, with no
significant differences noted in any of the individual groups
for EBL, LOS, and the distribution of minor and major
complications. Meanwhile, significant differences in com-
plication rates were seen only in the RLPN subgroup; dif-
ferences between this sub-analysis and the primary analysis
might be attributed to limitations in sample size (Table 4).
The relationships between the individual scoring param-
eters and outcomes are shown inTable 5. Multivariate analy-
sis revealed that the distance from the base of the tumor to
the renal sinus was significantly associated with EBL, WIT,
operative time and intraoperative complications. Larger
tumor diameter significantly influenced EBL and operative
time, whereas the anterior-posterior location significantly
affected EBL and WIT. The location within the polar lines
impacted WIT. The exophytic nature of the tumor was not
independently linked to intraoperative outcomes. Among
specific complications, distance to the renal sinus was asso-
ciated with increased renal hemorrhage, with an odds ratio
of 1.14 (1.00–1.30) per each one-point increase in nephrom-
etry subscore for “distance to sinus”, meaning closer dis-
tances to the renal sinus were associated with increased rates
of renal hemorrhage. No single individual scoring parameter
was predictive of any other specific complications.
Malignant tumors accounted for 69%, 96% and 88% of
the “low”, “intermediate” and “high” renal masses, respec-
tively (P = 0.001). The distance to the renal sinus was asso-
ciated with a higher rate of malignant tumors (P = 0.0006).
Positive margin rates were not significantly different
between groups (Table 2).
Discussion
The present study reviewed 298 patients undergoing
MI-NSS for suspected malignancy, with the goal of further
exploring the clinical role of the RENAL nephrometry
system. Perioperative outcomes of EBL, WIT, OR time and
LOS were found to increase with higher nephrometry
scores. In addition, the proportion of major complications,
as well as hemorrhage and respiratory complications, were
associated with higher nephrometry scores. Finally, we have
shown for the first time, to our knowledge, that individual
components of the RENAL nephrometry score are predic-
tive of outcomes, as summarized in Table 3.
The limitations of the present study deserve mention.
Individual preferences in managing small renal masses
might introduce bias. Tumor size and location dictate opera-
tive decision-making at our institution,13 with difficult
tumors, especially those adjacent to the hilum, preferentially
managed with RAPN. Additionally, institutional algorithms
help guide the choice of treatment with active surveillance,
extirpative therapy or ablation. Thus, patients presenting
with criteria favoring active surveillance or ablation were
Table 3 Type and severity of postoperative complications
by RENAL nephrometry score
Categorical variables Low Intermediate P
Severity of
complication
Minor 49 (93%) 75 (75%) <0.0001
Major 4 (7%) 25 (25%)
Type of complication
Wound 09 (17%) 7 (7%) 0.1288
Nerve 4 (7%) 0 (0%) 0.008
Pulmonary 4 (7%) 17 (17%) 0.3145
Cardiac 2 (4%) 11 (11%) 0.2663
ARF 1 (2%) 5 (5%) 0.5974
Urine leak 2 (4%) 4 (4%) 0.9384
Other 28 (53%) 39 (39%) 0.196
Hemorrhage 3 (6%) 17 (17%) 0.1088
Overall complication
rate (no.
patients with a
complication)
43 (32%) 71 (45%) 0.044
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not included in the present analysis. Furthermore, at our
institution, the most difficult tumors tend to be managed
with open NSS, as evidenced by the low proportion of
“high” complexity tumors in our study of MI-NSS. The
distribution of nephrometry scores in our series, however, is
similar to that reported in the literature of MI-NSS.7 Our
high rate of malignancy is likely explained by our heavy bias
towards renal biopsy. However, these results are more appli-
cable to the intended treatment of small renal masses, and
represent the expected outcomes of those patients that
require treatment.
Unmeasured variables might also introduce bias into our
results. Variations in surgeon technique, for instance, will
affect perioperative outcomes. The surgeon effect in our
series is difficult to determine given individual preferences
regarding surgical approach. Included in this review were
conventional laparoscopic and robotic approaches. Despite
the heterogeneous nature of this group, studies from our
group and others have shown few differences in outcomes
between these approaches.13,14 Furthermore, on sub-analysis
among these separate approaches, there did not appear to be
a single surgical approach whose outcomes “drove” the
overall differences seen. Thus, we feel that our findings are
indicative of a diverse academic practice and perhaps, as a
result, are a more rigorous assessment of the utility of the
nephrometry system.
These limitations notwithstanding, we believe our series
provides an important assessment of the RENAL nephrom-
etry scoring system in a heterogeneous, multi-surgeon prac-
tice, in what is to our knowledge, the largest external
validation of the RENAL scoring system for MI-NSS. The
present findings corroborate previous reports correlating the
RENAL system to perioperative outcomes, complications
and pathological features of small renal masses.7,15 No pre-
vious studies evaluated the importance of individual param-
Table 4 Sub-analysis of intra- and perioperative outcomes, stratiﬁed by RENAL nephrometry and surgical approach
CLPN HAPN RAPN
Low (n = 84) Intermediate
(n = 67)
Low (n = 9) Intermediate
(n = 26)
Low (n = 42) Intermediate
(n = 62)
Intraoperative outcomes
EBL (mL) (median, [range]) 150 (20–1700) 250 (25–5000) 300 (100–500) 450 (100–1400) 150 (5–1200) 250 (25–9000)
WIT (min) 10.8  13.9 26.1  14.4 10.7  9.4 29.3  12.1 22.4  9.3 30.0  11.2
Operative time (min) 139  51 184  64 168  41 210  46 206  47 230  55
Transfusion requirement 3 (4%) 4 (6%) 0 (0%) 6 (23%) 2 (5%) 4 (6%)
Positive margins 6 (11%) 3 (5%) 1 (14%) 0 (0%) 4 (13%) 3 (5%)
Postoperative outcomes
LOS (days) 2.2  1.5 2.5  2.0 3.0  1.6 4.3  3.4 2.5  1.8 3.3  2.4
eGFR 84.7  24.4 82.5  24.5 81.7  28.7 66.4  21.9 85.2  22.1 82.9  30.0
eGFR <60 10 (12%) 11 (16%) 2 (22%) 7 (27%) 5 (12%) 9 (15%)
New onset eGFR <60 2 (2%) 5 (8%) 0 (0%) 4 (15%) 2 (5%) 3 (5%)
Complications
# Patients with 1
complication
36 (43%) 28 (42%) 3 (33%) 15 (58%) 10 (24%) 31 (50%)
Minor complications 32 (91%) 22 (76%) 4 (100%) 22 (71%) 13 (93%) 31 (78%)
Major complications 3 (9%) 7 (24%) 0 (0%) 9 (29%) 1 (7%) 9 (22%)
Highlighted outcomes indicate P < 0.05 in comparisons between “Low” and “Intermediate” cohorts.
Table 5 Effect of individual components of RENAL neph-
rometry score on perioperative outcomes
R E N A L
EBL(mL)
WIT (min)
Operative time (min)
LOS (days)
Arrows indicate statistical signiﬁcance on multivariable
analysis. Up arrows indicate an increase in outcome with
higher RENAL nephrometry scores. The down arrow indi-
cates a decrease in outcome as associated with anterior
location. Black arrows: P < 0.0001. Gray arrows: P range
0.0001–0.01. White arrows: P range 0.01–0.05. A, Anterior/
Posterior location; E, Exophytic nature; L, Location within
Polar Lines; N, Nearness to Renal Sinus; R, Radius.
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eters of the RENAL system, as reported here. The RENAL
nephrometry score has been shown to be predictive of sur-
gical approach, with higher complexity tumors more likely
to receive open nephron-sparing or minimally invasive non-
nephron sparing surgery.16 However, recent data suggest
high complexity tumors can have similar outcomes with
both open and robotic partial nephrectomy.17 In this context,
the present findings regarding the importance of individual
RENAL parameters might serve to aid in risk-stratifying
patients with small renal masses, augmenting the total score
as well as existing gauges of comorbidity, such as perform-
ance status and the Charleston Comorbidity Index. These
findings might encourage more surgeons to pursue renal
mass biopsy, active surveillance or referral to high volume
surgeons for extirpative therapy for more complex renal
masses. Furthermore, surgeons might use these findings to
better inform patients about the risks inherent to their par-
ticular tumor. Certain factors, such as tumor diameter and
depth of invasion, appear to be more predictive of outcomes,
and these components might merit differential weighting
to further define patient-specific risk. Ultimately, however,
it is important to note that the present results confirm that
higher complexity tumors are amenable to nephron-sparing
surgery, albeit with greater yet acceptable perioperative
risks.
The future role of the RENAL scoring system in clinical
and investigative urology is yet to be solidified. The long-
term impact of nephron-sparing surgery for complex masses
with regards to oncological control and renal function still
warrants additional investigation. Better understanding the
effects of individual renal mass anatomical characteristics
might allow for further refinement of the scoring system.
Furthermore, multiple nephrometry scores, including the
RENAL score, Preoperative Aspects and Dimensions Used
for Anatomic classification and C-index have been proposed
for grading of tumor complexity. As limited data exist com-
paring these instruments, it remains unknown which scoring
system will gain traction in a clinical setting. However, the
RENAL system does have the advantage of being simple to
implement and reproducible.6 Based on the results presented
here, we believe the RENAL nephrometry system is useful
for surgeons for both preoperative and intraoperative
decision-making.
Thus, more complex tumors are associated with longer
operative times, warm ischemia times and greater blood
loss, as well as a higher proportion of severe complications.
The distance from the tumor to the renal sinus appears to be
the most influential individual component of the RENAL
system, although tumor diameter, polarity and anterior-
posterior location also have significant effects on outcomes.
The ultimate clinical and research role of current nephrom-
etry scoring systems remains to be seen, but the RENAL
system is useful for patient counseling, operative planning
and as a research instrument.
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Editorial Comment
Editorial Comment from Dr Herrel and Dr Canter to
Association of RENAL nephrometry score with outcomes of
minimally invasive partial nephrectomy
The RENAL nephrometry scoring system as first introduced
by Kutikov and Uzzo offers an objective measurement of the
salient factors contributing to the anatomical complexity of
a given renal mass.1 This tool creates a common language to
allow comparison of surgical techniques, complications,
pathological diagnosis and cancer control outcomes. In
addition to its predictive power, the RENAL nephrometry
scoring system is highly reproducible and easy to use. Since
its introduction, there have been over 80 peer-reviewed pub-
lications in which the RENAL nephrometry system has been
used to standardize outcome reporting stratified by tumor
complexity.
For example, Simhan et al. showed that more complex
tumors as quantified by a higher nephrometry score have
increasing rates of major urological complications in
patients undergoing nephron-sparing surgery.2 More
recently, Canter et al. showed that the nephrometry score of
a patient’s tumor predicted the choice of surgical procedure;
patients with more complex tumors as objectified by a
higher nephrometry score were more likely to undergo
radical nephrectomy.3 Similarly, patients with a low neph-
rometry score were more likely to undergo minimally inva-
sive nephron-sparing surgery.
In the article contained in this issue of the International
Journal of Urology, the authors implement the RENAL
nephrometry scoring system to stratify outcomes in patients
undergoing minimally invasive (pure laparoscopic or
robotic) partial nephrectomy.4 The authors showed the pre-
dictive ability of not only the nephrometry score sum, but
also the individual components of the scoring system.
Patients with increasingly complex tumors as quantified by
a higher nephrometry sum, as well as increasing individual
component scores, tended to have longer warm ischemia
times and length of stays, increased estimated blood loss
intraoperatively, and an increase in major complication
rates. In particular, in this study, the “N” variable, or
nearness to the collecting system, had the greatest associa-
tion with outcomes.
The utility of objective tools to predict outcomes cannot
be overstated. Statistical models and objective measures
offer physicians the ability to more precisely counsel
patients on the risks, complications and outcomes associated
with intervention on their disease process, thereby helping
to guide treatment decision-making. The goal of tools such
as the RENAL nephrometry scoring system is to replace
subjective “hunches” with objective decision-making to
improve patient care.
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